Erratum to ‘Targeting DLL3: A New Weapon in Lung Neuroendocrine Tumors?’ [JTO Clinical and Research Reports Volume 6 Issue 5 (2025) 100796]
Saved in:
Main Authors: | Mariona Riudavets, MD, PhD, David Planchard, MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-07-01
|
Series: | JTO Clinical and Research Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666364325000566 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Erratum to ‘Model-Based Cost-Utility Analysis of Combined Low-Dose Computed Tomography Screening for Lung Cancer, Chronic Obstructive Pulmonary Disease, and Cardiovascular Disease’ [JTO Clinical and Research Reports Volume 6 Issue 5 (2025) 100813]
by: Carina M. Behr, PhD, et al.
Published: (2025-07-01) -
Erratum to ‘Primary Results from IMscin002: A Study to Evaluate Patient Preferences and Perceptions of Health Care Professionals for Atezolizumab Subcutaneous Versus Intravenous for the Treatment of NSCLC’ [JTO Clinical and Research Reports Volume 6 Issue 5 (2025) 100815]
by: Federico Cappuzzo, MD, et al.
Published: (2025-07-01) -
Impact of Normal Lung Volume Choices on Radiation Pneumonitis Risk Prediction in Locally Non-small Cell Lung Cancer Radiation Therapy
by: Alyssa Gadsby, MS, et al.
Published: (2025-08-01) -
Corrigendum to Effects of the sampling time on the vaginal microbiota in healthy pregnant women: a prospective observational study’ [AJOG Global Reports Volume 5, Issue 1, February 2025, 100460]
by: Hiroshi Mori, MD, et al.
Published: (2025-05-01) -
Beyond the expected: MRI features of a primary retro-uterine neuroendocrine tumor: A case report
by: Zineb Ezzoulali, MD, et al.
Published: (2025-10-01)